Marine Polyether Compounds
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 2673
Special Issue Editor
Interests: organic synthesis; fatty acids; marine steroids; antitumor; lipids; alkaloids; terpenoids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Marine polyester compounds are a class of organic compounds that are derivatives of squalene, as well as polyunsaturated fatty acids, and possess a broad spectrum of antitumor activity withantimicrobial and antifungal effects.
For example, okadaic acid, also known as a marine polycyclic ether toxin, called gambierol, and its derivatives was discovered more than 50 years ago,among many others that produce marine dinoflagellates.
For more than fifty years, in many countries of the world, scholars have studied polyether compounds that were isolated from Actinobacteria belonging to the largest genus, Streptomyces.
These bacteria produce well-known antibiotics, such as tetronomycins, noboritomycins, monensins.
In addition to these antibiotics, ionophoric polyethers of the genus Streptomyces synthesizes promomycin, as well as the related ionophoric polyethers, such as A80438, mutalomycin and lomonomycin.
In addition, myxobacterium Sorangium is known to produce antibiotics called sorangicins.
These polyester compounds are produced by unicellular algae, red algae, sea sponges, and coelenterates or are accumulated by some marine organisms, such as bivalve molluscs. Thus, they are also known as phycotoxins and are largely produced by phytoplankton, in particular dinoflagellates and diatoms.
However, the activity of many polyester compounds and their derivatives has not yet been studied, but there is a strong belief that other types of biological activity may be discovered in the near future.
Prof. Dr. Valery Dembitsky
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- polyester compounds
- squalene
- polyunsaturated fatty acids
- antitumor
- antimicrobial
- antifungal okadaic acid
- phycotoxin
